Additional Details
-
A Study of Mosliciguat in PH-ILD
Ronald Reagan UCLA Medical CenterLos Angeles CA. 90024 -
A Study of Mosliciguat in PH-ILD
Harbor-UCLA Medical Center - TorranceTorrance CA. 90502 -
A Study of Mosliciguat in PH-ILD
Duke University Health System - Duke ClinicDurham NC. 27710 -
A Study of Mosliciguat in PH-ILD
University of Kansas Medical CenterKansas City KS. 66160 -
A Study of Mosliciguat in PH-ILD
University of Iowa Hospitals and ClinicsIowa City IA. 52242 -
A Study of Mosliciguat in PH-ILD
University of California Davis School of MedicineSacramento CA. 95817 -
A Trial to Evaluate Efficacy and Safety of Buloxibutid in People With Idiopathic Pulmonary Fibrosis.
Paradigm Clinical ResearchSan Diego CA. 92108 -
A Trial to Evaluate Efficacy and Safety of Buloxibutid in People With Idiopathic Pulmonary Fibrosis.
University of Utah, Health Sciences CenterSalt Lake City UT. 84108 -
A Trial to Evaluate Efficacy and Safety of Buloxibutid in People With Idiopathic Pulmonary Fibrosis.
Kelowna Respiratory & Allergy ClinicKelowna BC. V1W 1V3 -
A Trial to Evaluate Efficacy and Safety of Buloxibutid in People With Idiopathic Pulmonary Fibrosis.
Baylor Scott & White Research InstituteDallas TX. 75246 -
A Trial to Evaluate Efficacy and Safety of Buloxibutid in People With Idiopathic Pulmonary Fibrosis.
UAB Hospital, School of Medicine/Lung Health CenterBirmingham AL. 35233 -
A Trial to Evaluate Efficacy and Safety of Buloxibutid in People With Idiopathic Pulmonary Fibrosis.
Pierre-Le GardeurTerrebonne QC. J6V 2H2 -
A Trial to Evaluate Efficacy and Safety of Buloxibutid in People With Idiopathic Pulmonary Fibrosis.
University of New Mexico, Health Sciences CenterAlbuquerque NM. 87106 -
A Trial to Evaluate Efficacy and Safety of Buloxibutid in People With Idiopathic Pulmonary Fibrosis.
Laval HospitalLaval QC. G1V 4G5